Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
The pulmonary epithelial and vascular endothelial cell layers provide two sequential physical and immunological barriers that together form a semi-permeable interface and prevent alveolar and interstitial oedema formation. In this review, we focus specifically on the continuous endothelium of the pulmonary microvascular bed that warrants strict control of the exchange of gases, fluid, solutes and circulating cells between the plasma and the interstitial space. The present review provides an overview of emerging molecular mechanisms that permit constant transcellular exchange between the vascular and interstitial compartment, and cause, prevent or reverse lung endothelial barrier failure under experimental conditions, yet with a clinical perspective. Based on recent findings and at times seemingly conflicting results we discuss emerging paradigms of permeability regulation by altered ion transport as well as shifts in the homeostasis of sphingolipids, angiopoietins and prostaglandins.
The pulmonary epithelial and vascular endothelial cell layers provide two sequential physical and immunological barriers that together form a semi-permeable interface and prevent alveolar and interstitial oedema formation. In this review, we focus specifically on the continuous endothelium of the pulmonary microvascular bed that warrants strict control of the exchange of gases, fluid, solutes and circulating cells between the plasma and the interstitial space. The present review provides an overview of emerging molecular mechanisms that permit constant transcellular exchange between the vascular and interstitial compartment, and cause, prevent or reverse lung endothelial barrier failure under experimental conditions, yet with a clinical perspective. Based on recent findings and at times seemingly conflicting results we discuss emerging paradigms of permeability regulation by altered ion transport as well as shifts in the homeostasis of sphingolipids, angiopoietins and prostaglandins.
We read with great interest the recent manuscript by BOUVARD et al. [1], which suggested the gap junctional protein connexin-43 (Cx43) to be a promising target for the treatment of chronic hypoxic pulmonary hypertension (CHPH). Therein, the authors demonstrated increased Cx43 expression in human pulmonary arteries of CHPH patients, while heterozygous Cx43 deficient mice were partially protected from CHPH.These findings align with a series of previous studies highlighting the role of connexins in the pulmonary vascular response to hypoxia: I. McMurtry and co-workers first reported that the non-specific gap junction blocker 18α-glycyrrhetinic acid blunts the acute vasoconstrictive response to hypoxia in isolated perfused rat lungs [2]. Using a combination of small peptide inhibitors and gene deficient mice, subsequent work by our own groups demonstrated that both connexin-40 (Cx40) and Cx43 contribute additively to hypoxic pulmonary vasoconstriction, and that Cx40 deficient mice are largely protected from the development of CHPH [3]. Attenuation of the vasoconstrictive response of pulmonary arteries to hypoxia in vivo and ex vivo by 18α-glycyrrhetinic acid was further confirmed by the laboratory of J.P.T. Ward and P.I. Aaronson [4]. Consistent with these reports, the findings by BOUVARD et al.[1] consolidate the requirement of connexins for the pulmonary vascular response to hypoxia. Notably, however, this concept has recently been challenged by a report that Cx40 deficient mice develop more severe CHPH, which can be attenuated by adenoviral Cx40 overexpression [5]. The reason for the obvious discrepancy between these [5] and earlier [3] findings remains unclear.Connexins are the building blocks of gap junctions, i.e. they form intercellular communication "channels" composed of two opposing homo-or heterotypic (i.e. identical or not) connexons, each of which is again a hexamer consisting of six identical (homomeric) or different (heteromeric) connexins [6]. In the vasculature, gap junctions are typically composed of one of three connexins, namely connexins 37, 40 and 43 [6]. In the systemic circulation, vascular gap junctions have been long recognised as important "highways" for retrograde signal conduction from capillaries to upstream arterioles in order to match resistance vessel tone and, thus, blood flow to local demands in the "downstream" tissue. In the lung, an analogous signal propagation from capillaries to upstream arterioles mediates the pulmonary vascular response to hypoxia. This signal conduction is required due to the spatial separation between the site of gas exchange, i.e. the alveolo-capillary compartment, and the site of vasoconstriction and vascular remodelling in response to acute and chronic hypoxia, respectively, which are localised in upstream arterioles [3,7]. Although direct visualisation of gas exchange in intact lungs by multispectral oximetry has revealed relevant precapillary oxygenation, indicating that alveolar hypoxia can directly impact oxygen tension (PO 2 ) in the vascular wall o...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.